Company intelligence / Profile preview

Aromics

Barcelona, Catalonia, Spainaromics.es ↗
Ownership
Private
Employees
~50
Development stage
Preclinical
01

Overview

Aromics’ lead compound is a small molecule drug targeting malignant mesothelioma and other cancers. It works by binding to mRNA and blocking production of a key enzyme needed for tumor growth. The company uses omics technologies to identify biomarkers and improve patient selection. Their approach aims to overcome resistance seen with current chemotherapy options like pemetrexed and cisplatin. Clinical results are not detailed publicly but the company’s focus remains on drug-resistant cancers with high unmet need.[1][3][4]

Therapeutic areas
OtherOncology
Modalities
Small moleculesOmics-based diagnostics (genomics, proteomics)
Industry
Biotech
02

Drug pipeline

3 assets

NAX035

1

2 more assets in the full pipeline.

Request access →
03

Partnerships

Not explicitly listed; participates in EU-funded projects such as Bermes Project[3]

Beyond the preview

Go deeper on Aromics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aromics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call